View from the Thoraxcenter: ACC.24 Late-breaking Science Preview

Published: 25 Mar 2024

  • Views:

    Views Icon 743
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

What’s hot at ACC.24?

Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.

This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24, highlighting their context and relevance for practice.

Trials covered include:
0:42 - IVUS-ACS: Intravascular Ultrasound-guided Versus Angiography-guided Percutaneous Coronary Intervention in Acute Coronary Syndromes
2:22 - Ultimate DAPT: One-month Ticagrelor Monotherapy After PCI in Acute Coronary Syndromes
4:02 - RELIEVE-HF: A Double-blind, Randomized Placebo Procedure-controlled Trial of an Interatrial Shunt in Patients With HFrEF and HFpEF
6:52 - ORBITA-COSMIC: Coronary Sinus Reducer for the Treatment of Refractory Angina
8:52 -  EMPACT-MI: Empagliflozin After Acute Myocardial Infarction
10:15 - REDUCE-AMI: Long-term Beta-blocker Treatment After Acute Myocardial Infarction and Preserved Left Ventricular Ejection Fraction
12:39 - SMART: Self-expanding Versus Balloon-expandable Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annuli
14:44 - DEDICATE-DZHK6: Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients at Low to Intermediate Risk
16:56 - PERFORM-TAVR: Protein and Exercise to Reverse Frailty in Older Men and Women Undergoing Transcatheter Aortic Valve Replacement
18:13 - PREVENT: Preventive PCI or Medical Therapy Alone for Atherosclerotic Coronary Vulnerable Plaques
21:32 - FULL REVASC: Ffr-guidance for complete non-culprit REVASCularization
22:46 - DanGer Shock: Danish-German cardiogenic shock trial
25:18 - TARGET BP I: Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs


You must be to comment. If you are not registered, you can register here.
Theodore Spiro
Grat overview of what is to come at ACC 2024